Exchange: NASDAQ·Updated 07:46 PM EST

ISPC News

News
all
press releases
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
Gainers iSpecimen (NASDAQ:ISPC) stock increased by 22.7% to $1.89 during Tuesday's pre-market session. The company's market cap stands at $3.8 million. Bluejay Diagnostics (NASDAQ:BJDX) shares moved upwards byread more...
Benzinga
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
Gainers iSpecimen (NASDAQ:ISPC) stock increased by 22.7% to $1.89 during Tuesday's pre-market session. The company's market cap stands at $3.8 million. Bluejay Diagnostics (NASDAQ:BJDX) shares moved upwards byread more...
Benzinga
More News
iSpecimen surged 27.9% premarket on a $4.5M Foldlab AI asset deal; CEA Industries led gainers, while Focus Universal plunged 51.2%.read more...
Benzinga
Gainers iSpecimen (NASDAQ:ISPC) shares increased by 10.4% to $1.7 during Friday's after-market session. The market value of their outstanding shares is at $3.8 million. Genelux (NASDAQ:GNLX) stock moved upwards byread more...
Benzinga
iSpecimen Inc (NASDAQ: ISPC) stock is trading higher Friday after announcing a shipping overhaul that slashes transit times by up to 85%.read more...
Benzinga
iSpecimen (NASDAQ:ISPC) is making a significant operational leap, announcing a revamped logistics model that dramatically reduces the time it takes to deliver human biospecimens to researchers worldwide.
24-7 Market News
President Donald Trump criticized Iran late night on Thursday for reportedly collecting toll from tankers trying to pass through the Strait of Hormuz.
Stocktwits
Clearsign Technologies Corp (NASDAQ: CLIR) shares rose 11.3% in pre-market trading after reporting better-than-expected quarterly results. Other gainers include iSpecimen Inc, Wellgistics Health Inc...
Benzinga
iSpecimen Inc. shares surge over 56% in after-hours trading after announcing faster shipping and expanded European sourcing, despite weak fourth-quarter results.read more...
Benzinga
Artificial intelligence is rapidly transforming the life sciences industry, particularly in areas where speed and precision can dramatically impact research outcomes. From drug discovery to clinical data analysis, AI-powered tools are increasingly helping scientists process vast amounts of information and connect critical research resources faster than ever before. One emerging application is the use of intelligent platforms to streamline access to human biospecimens, an essential component in developing diagnostics, therapies, and medical breakthroughs.Shares of iSpecimen Inc. (NASDAQ: ...
AllPennyStocks.com
Artificial intelligence is rapidly transforming the life sciences industry, particularly in areas where speed and precision can dramatically impact research outcomes. From drug discovery to clinical data analysis, AI-powered tools are increasingly helping scientists process vast amounts of information and connect critical research resources faster than ever before. One emerging application is the use of intelligent platforms to streamline access to human biospecimens, an essential component in developing diagnostics, therapies, and medical breakthroughs.Shares of iSpecimen Inc. (NASDAQ: ...
AllPennyStocks.com

Advertisement|Remove ads.